Similar articles

• Pro: 'Antithrombotic therapy with warfarin, aspirin and clopidogrel is the recommended regime in anticoagulated patients who present with an acute coronary syndrome and/or undergo percutaneous coronary interventions'.

  Rubboli A, Halperin JL. Rubboli A, et al. Thromb Haemost. 2008 Nov;100(5):752-3. Thromb Haemost. 2008. PMID: 18989515 No abstract available.
• Contra: 'Antithrombotic therapy with warfarin, aspirin and clopidogrel is the recommended regimen in anticoagulated patients who present with an acute coronary syndrome and/or undergo percutaneous coronary interventions'. Not for everybody.

  Roldán V, Marín F. Roldán V, et al. Thromb Haemost. 2008 Nov;100(5):754-5. Thromb Haemost. 2008. PMID: 18989516 No abstract available.
• Antithrombotic treatment of NSTEMI/UAP. The interaction with PCI.

  Otterstad JE, Brosstad F. Otterstad JE, et al. Scand Cardiovasc J. 2004 Mar;38(1):9-15. doi: 10.1080/14017430310016199. Scand Cardiovasc J. 2004. PMID: 15204241 Review. No abstract available.
• Review of antithrombotic agents used for acute coronary syndromes in renal patients.

  Fernandez JS, Sadaniantz BT, Sadaniantz A. Fernandez JS, et al. Am J Kidney Dis. 2003 Sep;42(3):446-55. doi: 10.1016/s0272-6386(03)00800-x. Am J Kidney Dis. 2003. PMID: 12955672 Review.
• [Antithrombotic treatment in acute coronary syndrome].

  Darius H, Rupprecht HJ, Genth-Zotz S, Wittlinger T, Zotz R. Darius H, et al. Dtsch Med Wochenschr. 2014 Jan;139 Suppl 1:S17-22. doi: 10.1055/s-0033-1359997. Epub 2014 Jan 20. Dtsch Med Wochenschr. 2014. PMID: 24446037 Review. German. No abstract available.